Nilutamide (ANI Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Nilutamide drug offered from ANI Pharmaceuticals, Inc.. This Androgen Receptor Antagonists [MoA],Androgen Receptor Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | ANI Pharmaceuticals, Inc. |
NON-PROPRIETARY NAME: | Nilutamide |
SUBSTANCE NAME: | NILUTAMIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Androgen Receptor Antagonists [MoA],Androgen Receptor Inhibitor [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2016-07-18 |
END MARKETING DATE: | 0000-00-00 |
Nilutamide HUMAN PRESCRIPTION DRUG Details:
Item Description | Nilutamide from ANI Pharmaceuticals, Inc. |
LABELER NAME: | ANI Pharmaceuticals, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 150(mg/1) |
START MARKETING DATE: | 2016-07-18 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 62559-173_8d6d69d9-891a-4587-8c70-a74f46232c56 |
PRODUCT NDC: | 62559-173 |
APPLICATION NUMBER: | ANDA207631 |
Other NILUTAMIDE Pharmaceutical Manufacturers / Labelers: